Free Trial

Kanabo Group (KNB) Competitors

Kanabo Group logo
GBX 0.22 0.00 (0.00%)
As of 07/16/2025

KNB vs. TLY, SPI, MGP, SBI, ODX, HEMO, OBD, MHC, BNR, and GENI

Should you be buying Kanabo Group stock or one of its competitors? The main competitors of Kanabo Group include Totally (TLY), Spire Healthcare Group (SPI), Medica Group (MGP), Sourcebio International (SBI), Omega Diagnostics Group (ODX), Hemogenyx Pharmaceuticals (HEMO), Oxford BioDynamics (OBD), MyHealthChecked (MHC), Burning Rock Biotech (BNR), and GENinCode (GENI). These companies are all part of the "medical" sector.

Kanabo Group vs. Its Competitors

Kanabo Group (LON:KNB) and Totally (LON:TLY) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends.

Totally has a net margin of -2.85% compared to Kanabo Group's net margin of -717.63%. Totally's return on equity of -11.01% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Kanabo Group-717.63% -121.77% -20.89%
Totally -2.85%-11.01%-2.42%

Totally has a consensus price target of GBX 20, suggesting a potential upside of 7,900.00%. Given Totally's stronger consensus rating and higher possible upside, analysts clearly believe Totally is more favorable than Kanabo Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Kanabo Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Totally
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

3.8% of Kanabo Group shares are owned by institutional investors. Comparatively, 51.3% of Totally shares are owned by institutional investors. 37.0% of Kanabo Group shares are owned by insiders. Comparatively, 13.3% of Totally shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Kanabo Group has a beta of 3.04, indicating that its share price is 204% more volatile than the S&P 500. Comparatively, Totally has a beta of 0.55, indicating that its share price is 45% less volatile than the S&P 500.

Totally has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Totally, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Kanabo Group£1.14M1.25-£8.18M-£1.29-0.17
Totally£133.05M0.00-£3.79M-£1.93-0.13

In the previous week, Totally had 3 more articles in the media than Kanabo Group. MarketBeat recorded 3 mentions for Totally and 0 mentions for Kanabo Group. Kanabo Group's average media sentiment score of 0.00 beat Totally's score of -0.13 indicating that Kanabo Group is being referred to more favorably in the media.

Company Overall Sentiment
Kanabo Group Neutral
Totally Neutral

Summary

Totally beats Kanabo Group on 11 of the 16 factors compared between the two stocks.

Get Kanabo Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for KNB and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KNB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KNB vs. The Competition

MetricKanabo GroupMedical Care Facilities IndustryMedical SectorLON Exchange
Market Cap£1.42M£1.55B£5.54B£3.02B
Dividend YieldN/A4.04%3.75%5.02%
P/E Ratio-0.176.9921.01165.88
Price / Sales1.2514.12433.81285,131.44
Price / Cash1.8212.3236.1627.97
Price / Book0.241.898.124.46
Net Income-£8.18M£58.06M£3.25B£5.90B
7 Day PerformanceN/A-3.28%0.97%3.82%
1 Month PerformanceN/A0.91%7.36%9.81%
1 Year Performance-83.31%41.07%31.31%74.29%

Kanabo Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KNB
Kanabo Group
N/AGBX 0.23
flat
N/AN/A£1.42M£1.14M-0.1720
TLY
Totally
2.8315 of 5 stars
GBX 0.25
+4.2%
GBX 20
+7,900.0%
-97.4%£491K£133.05M-0.131,668Gap Down
SPI
Spire Healthcare Group
1.6759 of 5 stars
GBX 222
-1.1%
GBX 300
+35.1%
-7.0%£891.48M£1.44B31.60420
MGP
Medica Group
N/AN/AN/AN/A£259.85M£76.98M3,516.671,212
SBI
Sourcebio International
N/AN/AN/AN/A£85.31M£75.61M1,277.78194Gap Up
High Trading Volume
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55M-220.0091Gap Down
HEMO
Hemogenyx Pharmaceuticals
N/AGBX 144.28
-0.5%
N/A+10,478.4%£5.14MN/A-738.0414
OBD
Oxford BioDynamics
N/AGBX 0.26
+1.6%
N/A-94.2%£4.88M£5.75M-0.0545
MHC
MyHealthChecked
N/AGBX 9.20
-8.0%
N/A+59.8%£4.79M£9.43M-4.5916Gap Down
BNR
Burning Rock Biotech
N/AN/AN/AN/A£3.77MN/A0.001,390Gap Down
High Trading Volume
GENI
GENinCode
N/AGBX 2
+5.3%
N/A-61.9%£3.55M£2.67M-0.582,300Gap Up

Related Companies and Tools


This page (LON:KNB) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners